entecavir 0.5 MG Oral Tablet

1 INDICATIONS AND USAGE Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. Entecavir is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. ( 1 )

American Health Packaging

FDA Reported Adverse Reactions
`[1] drug interaction` `[2] depression` `[3] diarrhoea` `[4] off label use` `[5] nausea` `[6] drug ineffective` `[7] pain` `[8] anxiety` `[9] vomiting` `[10] fatigue`

3 months ago

TRIANGLE WHITE K 40

3 months ago

K 40 TRIANGLE WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

ENTECAVIR Tablets USP 0.5 mg are white, triangular shaped, biconvex, film-coated tablets, debossed with ‘K’ on one side and ‘40’ on the other side. Unit dose packages of 30 (5 x 6) NDC 60687-216-25 Storage

ENTECAVIR tablets USP should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. FOR YOUR PROTECTION: Do not use if blister is torn or broken.

More pills like TRIANGLE K 40

Related Pills

Glycopyrrolate 2 MG Oral Tablet

par pharmaceutical, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site